Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
BNTX

Updated 10/6/2026, 8:56 AM ET.

BNTX

BioNTech SE

Sale$3,301,069

Sahin Ugur

Chief Executive Officer, 10% owner

34,000 shat $97.09Filed Oct 2, 4:27 PM ET
Filing
BNTX

BioNTech SE

Sale$6,480,659

Sahin Ugur

Chief Executive Officer, 10% owner

66,000 shat $98.19Filed Sep 30, 4:29 PM ET
Filing
BNTX

BioNTech SE

Sale$6,012,500

Sahin Ugur

Chief Executive Officer, 10% owner

61,000 shat $98.57Filed Sep 28, 5:16 PM ET
Filing
BNTX

BioNTech SE

Sale$6,842,742

Sahin Ugur

Chief Executive Officer, 10% owner

69,000 shat $99.17Filed Sep 24, 4:26 PM ET
Filing
BNTX

BioNTech SE

Sale$7,860,757

Sahin Ugur

Chief Executive Officer, 10% owner

79,000 shat $99.50Filed Sep 22, 5:04 PM ET
Filing
BNTX

BioNTech SE

Sale$6,239,071

Sahin Ugur

Chief Executive Officer, 10% owner

64,000 shat $97.49Filed Sep 18, 4:41 PM ET
Filing
BNTX

BioNTech SE

Sale$4,721,976

Sahin Ugur

Chief Executive Officer, 10% owner

49,000 shat $96.37Filed Sep 16, 4:46 PM ET
Filing
BNTX

BioNTech SE

Sale$8,439,336

Sahin Ugur

Chief Executive Officer, 10% owner

86,000 shat $98.13Filed Sep 14, 4:50 PM ET
Filing
BNTX

BioNTech SE

Sale$1,974,287

Sahin Ugur

Chief Executive Officer, 10% owner

20,500 shat $96.31Filed Sep 11, 5:18 PM ET
Filing
BNTX

BioNTech SE

Sale$7,190,663

Sahin Ugur

Chief Executive Officer, 10% owner

73,000 shat $98.50Filed Sep 9, 5:29 PM ET
Filing
BNTX

BioNTech SE

Sale$7,889,055

Sahin Ugur

Chief Executive Officer, 10% owner

76,500 shat $103.12Filed Sep 8, 4:10 PM ET
Filing

Read from public SEC filings. Not financial advice.